Yoga Therapy and Aerobic Exercise on Anti-Mullerian Hormone in Young Women With Polycystic Ovary Syndrome
1 other identifier
interventional
128
1 country
2
Brief Summary
Weight loss and lifestyle modifications are much required in women with Polycystic ovarian syndrome (PCOS). Yoga has gained great importance as an alternate medicine in recent years which is helpful in lifestyle modifications. Weight loss can be achieved by regular aerobic activity. In recent years, excessive production of anti-mullerian hormone (AMH) has been considered as the etiology of PCOS. AMH is also emerging as a diagnostic and screening tool for PCOS. Effect of yoga therapy on adolescent girls have proved to be effective. But, researches on young women undergoing yoga therapy and combined effect of aerobic exercise and yoga therapy are still lacking. Hence, the investigators aimed t o establish the benefits of yoga therapy and aerobic exercise on Anti-Mullerian Hormone and other biochemical markers in young women with polycystic ovary syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2020
CompletedFirst Posted
Study publicly available on registry
April 6, 2020
CompletedStudy Start
First participant enrolled
November 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2023
CompletedAugust 24, 2021
August 1, 2021
1.3 years
March 27, 2020
August 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum Anti-Mullerian hormone Concentration
Serum Anti-Mullerian hormone will be determined by blinded lab technician
Change from Baseline Serum Anti-Mullerian hormone Concentration at 12 weeks
Secondary Outcomes (11)
Antral follicle count
Change from Baseline Antral follicle count at 12 weeks
Serum Follicle-stimulating hormone Concentration
Change from Baseline Serum Follicle-stimulating hormone Concentration at 12 weeks
Serum Luteinizing hormone Concentration
Change from Baseline Serum Luteinizing hormone Concentration at 12 weeks
Serum Testosterone Concentration
Change from Baseline Serum Testosterone Concentration at 12 weeks
Serum Prolactin Concentration
Change from Baseline Serum Prolactin Concentration at 12 weeks
- +6 more secondary outcomes
Study Arms (4)
Yoga therapy group
EXPERIMENTALStructured yoga therapy program for 60 minutes six days per week for 12 weeks and nutritional management uniquely prepared by dietitian
Aerobic exercise group
EXPERIMENTALAerobic training of moderate intensity for 30-60 minutes six days per week for 12 weeks and nutritional management uniquely prepared by dietitian
Combined yoga therapy and aerobic exercise group
EXPERIMENTALCombined yoga therapy for three days and vigorous aerobic exercise program for three days with nutritional management uniquely prepared by dietitian
Control group
ACTIVE COMPARATORNutritional management uniquely prepared by dietitian
Interventions
Structured yoga therapy prepared according to traditional yoga scriptures of Patanjali yoga sutras will be administered to 32 females with PCOS. The structured yoga therapy which includes, Surya Namaskara (Sun Salutation) and asanas performed in four positions, standing, sitting, supine and prone for total duration of 60 minutes. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian
Thirty two females with PCOS in aerobic exercise (AE) group will be subjected to aerobic training of moderate intensity for 30-60 minutes six days per week for 12 weeks, in the light of guidelines framed by American College of Sports Medicine (ACSM). Aerobic exercise volume for each female recruited will be set at greater than 500 and up to 1000 MET-min/week, which will be approximately equal to 1000 kcal/week. They will be made sure that they exercise for minimum duration of 150 min/week and thereby covering 5400 to 7900 steps/day in pedometer readings. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian
Thirty two females with PCOS in combined yoga therapy and aerobic exercise (cYTAE) group will be subjected to three days of structured yoga therapy and three days of aerobic training of vigorous intensity. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian
Thirty two females with PCOS will be asked to undergo only nutritional management uniquely prepared by dietitian
Eligibility Criteria
You may qualify if:
- Female in age between 18 and 30 years
- Female with at least two-thirds of the features listed in the Rotterdam criteria for PCOS were included in the study
- Oligomenorrhea or amenorrhea (an absence of menstruation for 45 or more days and/or fewer than 9 menses per year)
- Hyperandrogenism (a score of 8 or higher ( ≥ 8) on the modified Ferriman-Gallwey scale)
- Polycystic ovaries (presence of more than 12 cysts \< 9 mm in diameter in single ovary, usually combined with an ovarian volume \> 10 ml
You may not qualify if:
- On regular hormonal treatment
- Oral contraceptives
- Insulin-sensitizing agents in the previous 6 weeks
- Smoking in less than 48 hours
- Alcohol in less than 48 hours
- History of thyroid abnormalities
- Practicing regular yoga asanas and pranayama
- Regular aerobic training program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Maharishi Markandeshwar Hospital, Mullana
Ambāla, Haryana, 133207, India
Maharishi Markandeshwar Medical College & Hospital, Kumarhatti
Solan, Himachal Pradesh, 173229, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asir J Samuel, MPT, PhD
Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation, Mullana
- STUDY DIRECTOR
Unmesh Santpur, MBBS, MD
Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana
- STUDY CHAIR
Kiranjeet Kaur, MBBS, MD
Maharishi Markandeshwar Medical College & Hospital, Solan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Lab technician who test the blood samples of the female with Polycystic Ovary Syndrome (PCOS) will be blinded to the trial
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 27, 2020
First Posted
April 6, 2020
Study Start
November 14, 2021
Primary Completion
March 12, 2023
Study Completion
April 14, 2023
Last Updated
August 24, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share
Not now